|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.86 USD | -2.45% |
|
-3.96% | +0.13% |
| 12-03 | Qiagen N.V. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10:50 AM | |
| 12-02 | Qiagen N.V. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 11:15 AM |
| Capitalization | 10.19B 8.77B 8.24B 7.66B 14.11B 919B 15.4B 95.99B 37.17B 434B 38.26B 37.44B 1,590B | P/E ratio 2025 * |
24.5x | P/E ratio 2026 * | 22.4x |
|---|---|---|---|---|---|
| Enterprise value | 10.52B 9.06B 8.5B 7.9B 14.57B 948B 15.89B 99.07B 38.36B 448B 39.49B 38.64B 1,641B | EV / Sales 2025 * |
5.06x | EV / Sales 2026 * | 4.74x |
| Free-Float |
97.04% | Yield 2025 * |
0.44% | Yield 2026 * | 0.4% |
Last Transcript: Qiagen N.V.
| 1 day | -2.45% | ||
| 1 week | -3.13% | ||
| Current month | -3.96% | ||
| 1 month | +6.23% | ||
| 3 months | -3.61% | ||
| 6 months | -0.67% | ||
| Current year | +0.13% |
| 1 week | 45.66 |  | 47.48 |
| 1 month | 43.02 | | 48.69 |
| Current year | 37.63 | | 51.88 |
| 1 year | 37.63 | | 51.88 |
| 3 years | 36.84 | | 54.27 |
| 5 years | 36.84 | | 62.56 |
| 10 years | 21.96 | | 62.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 2019-10-06 |
Roland Sackers
DFI | Director of Finance/CFO | 57 | 2003-12-31 |
Antonio Santos
COO | Chief Operating Officer | - | 2022-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Metin Colpan
BRD | Director/Board Member | 70 | 2003-12-31 |
| Director/Board Member | 76 | 2011-05-31 | |
Ross Levine
BRD | Director/Board Member | 53 | 2015-12-31 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 3.1% | 1 M€ | 0.00% | - |
| 1.65% | 2 M€ | -.--% | - |
| 1.32% | 148 M€ | +17.71% | - |
| 1.08% | 5 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.45% | -3.13% | +0.60% | -12.08% | 10.19B | |
| +0.99% | -0.25% | +5.06% | +17.32% | 47.37B | |
| -1.01% | -2.14% | +8.30% | +6.25% | 38.46B | |
| +1.11% | -2.71% | +57.25% | +62.61% | 35.73B | |
| +2.07% | +0.81% | +13.44% | +21.77% | 27.23B | |
| +0.19% | -6.60% | +55.92% | +161.68% | 15.44B | |
| +0.53% | +5.62% | +70.20% | +223.47% | 15.4B | |
| -2.03% | +1.33% | -16.94% | -8.26% | 14.19B | |
| +0.50% | +4.01% | +65.68% | - | 13.64B | |
| -0.21% | -0.59% | +111.28% | +114.50% | 13.23B | |
| Average | +0.01% | -1.57% | +37.08% | +65.25% | 23.09B | |
| Weighted average by Cap. | +0.34% | -1.72% | +30.53% | +51.11% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.08B 1.79B 1.68B 1.56B 2.88B 187B 3.14B 19.56B 7.58B 88.43B 7.8B 7.63B 324B | 2.2B 1.9B 1.78B 1.65B 3.05B 198B 3.33B 20.73B 8.03B 93.71B 8.26B 8.09B 343B |
| Net income | 421M 362M 340M 316M 583M 37.94B 636M 3.96B 1.53B 17.91B 1.58B 1.55B 65.63B | 460M 396M 371M 345M 636M 41.44B 694M 4.33B 1.68B 19.56B 1.73B 1.69B 71.68B |
| Net Debt | 327M 282M 264M 246M 453M 29.49B 494M 3.08B 1.19B 13.92B 1.23B 1.2B 51B | 235M 202M 190M 176M 325M 21.17B 355M 2.21B 856M 9.99B 881M 862M 36.61B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-08 | 45.86 $ | -2.45% | 1,356,343 |
| 25-12-05 | 47.01 $ | -0.15% | 1,854,330 |
| 25-12-04 | 47.08 $ | +0.56% | 1,851,787 |
| 25-12-03 | 46.82 $ | -0.26% | 1,326,186 |
| 25-12-02 | 46.94 $ | -0.84% | 1,254,419 |
Delayed Quote Nyse, December 08, 2025 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- QGEN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition